Hebah Taufik MBBS, Presenter: Nothing to Disclose

Shelley Chapman MBBCHIR, Abstract Co-Author: Nothing to Disclose

Alexander Theodore Chapman MBBS, BSc, Abstract Co-Author: Nothing to Disclose

Allan Irvine, Abstract Co-Author: Nothing to Disclose

Our centre has a relatively small volume of carotid artery stenting cases. A robust pathway is essential for the selection and follow-up of cases. Rigorous audit ensures that the outcomes in smaller hospitals are comparable to national figures.    

Carotid artery stenting (CAS) is recommended as a second-line treatment for symptomatic patients unsuitable for endarterectomy.  The British Society of Interventional Radiologists (BSIR) developed the United Kingdom Carotid Artery Stent Registry (UKCASR) to monitor short and long-term outcomes of CAS. Recently published outcomes for 953 symptomatic and 201 asymptomatic cases undergoing CAS in UK hospitals between 1998-2010. 30- day outcomes for stroke/myocardial infarction/ death rate was 5.5% and death rate was 1.7% for symptomatic cases. For asymptomatic cases, 2.8% and 0.6%, respectively. At our district general hospital, we analysed 44 cases. 30- day outcome of stroke/ myocardial infarction/ death rate for both symptomatic and asymptomatic cases was 0%. Post-procedure duplex scans at our institute was suboptimal. 34.8% of symptomatic cases and 15.4% of asymptomatic cases were followed up within the recommended 6 week period. Using ECST, NASCET, NICE guidelines, along with the report published by UKCASR and our own experiences, we have proposed a CAS Patient Pathway. 

http://abstract.rsna.org/uploads/2014/14000845/14000845_txqs.pdf

Taufik, H, Chapman, S, Chapman, A, Irvine, A, Carotid Artery Stenting: Avoiding a Surgical Pain in the Neck.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14000845.html